membrane and metabolism was significantly enriched. In addition, Tumor Mutation Burden (TMB) and immune checkpoint genes expression were higher in the high-risk group. Furthermore, the high-risk group
highlight risky model regions; and (3) Governance artefacts such as explanation logs and transparency checkpoints that embed accountability in the MLOps life-cycle. Methodologically, the work triangulates evidence from
Problem: There is an unmet need regarding biomarkers of response to immune checkpoint inhibitors (ICI). Recently, a retrospective-studies based metaanalysis revealed improved survival and response rates in patients…
targeted and effective treatment options for autoimmune disorders. We discuss the evolving landscape of checkpoint inhibitors, engineered T-cell therapies, B-cell targeting approaches, and present a detailed examination
Recent advancements in molecular biology have identified Janel targets forintervention, including cytokine inhibitors, immune checkpoint modulators, and small molecule inhibitors that regulatethese inflammatory…
cancer, engineered antibodies can enhance immune responses by targeting tumorspecific antigens or modulating immune checkpoints, while in infectious diseases, antibodies can directly neutralizepathogens or prevent…
novel approaches designed to enhanceimmune system function and improve patient outcomes. These include immune checkpoint inhibitors, CAR-T (chimericantigen receptor T-cell) therapy, cancer vaccines, oncolytic virus…
regression and multivariate Cox regression analyses. Additionally, we investigated biological functions, response to Immune Checkpoint Inhibitors (ICIs), as well as Tumor Mutational Load (TMB) mutations in high and…
counteract these threats, cells have evolved sophisticated systems, including DNA damage recognition, repair pathways, checkpoint activation, and apoptosis. This article provides an in-depth exploration of the key…
lymphocytes are eliminated or rendered anergic. Peripheral tolerance mechanisms, including regulatory T cells (Tregs), checkpoint molecules, and the role of the microbiome, ensure that self-reactive cells are controlled
cancer-associated epigenetic changes, reactivating silenced tumor suppressor genes and sensitizing tumors to immune checkpoint inhibitors and other therapies. Furthermore, engineered OVs capable of delivering epigenetic…
Bell's palsy is one such irADR that has been previously reported with Immune Checkpoint Inhibitors (ICI) use in other cancers, but it has not been reported in triple-negative
shows promise, improving overall survival rates and response to treatment. For instance, trials utilizing checkpoint inhibitors in combination with standard chemotherapies have extended disease-free survival
autoimmune diseases, focusing on the development of biologic agents, small molecules, and immune checkpoint inhibitors. We discuss the mechanisms of action, clinical outcomes, and potential challenges associated with…
necessary for most cases of early-stage breast cancer and may involve immune checkpoint inhibitors. Endocrine therapy and chemotherapy are the most common therapies for persons with hormone-positive
molecular pathways involved in tolerance, highlighting the role of regulatory T cells, immune checkpoint molecules, and the role of antigen-presenting cells in modulating the immune response. Moreover, the development
more personalized and effective treatment options for patients with specific genetic profiles. Immunotherapy, particularly checkpoint inhibitors, has emerged as a promising strategy, leveraging the body’s immune system…
particularly with temozolomide for glioblastomas, have become standard, while emerging immunotherapy options, such as checkpoint inhibitors, hold promise for enhancing treatment efficacy
recognize and destroy cancer cells. Several types of immunotherapy have shown tremendous promise: Checkpoint inhibitors: These drugs block proteins that prevent the immune system from attacking cancer cells. Drugs like
LUAD samples, 59 normal lung samples and 54 patients who were treated with Immune Checkpoint Blockades (ICB) for Non-Small Cell Lung Cancer (NSCLC). To determine the correlation between BIRC5
Introduction: Avelumab is an immune checkpoint inhibitor (ICI) indicated for the treatment of patients with Merkel cell carcinoma and locally advanced or metastatic renal or urothelial carcinoma. ICIs enhance
involved in programmed cell death-ligand 1 expression and the programmed cell death-1 checkpoint pathway in cancer, T helper 17 cell differentiation, and the nuclear factor kappa B signaling
lung cancer. Both ACE and ACE2 were found highly co-expressed with different immune checkpoints. Analysis of protein-protein interaction based on STRING database gained top 10 genes which could
Statement of the problem: There has been significant progress in immune checkpoint inhibitor (ICI) therapy in using anti-PD-1 and or anti-CTLA-4 in many solid tumor types
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.